Delivery Order SPE2DB20D3505-SPE2DB22FT5A7
Award Date 3/1/22
Potential Completion Date 3/2/22
Potential Value $4.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication to the Defense Logistics Agency (DLA). The $1,431.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension (60 ml) to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The single-award, firm-fixed-price delivery order, valued at $1,524.36, was issued to the Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The fixed-price delivery order has a ceiling value of $1,640.44 and a completion date of January 26, 2023. The award was made on January 25, 2023, and there was no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a key vendor for...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,419.60, was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with an ultimate completion date of October 28, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 27, 2021, with a ceiling value of $1,129.45. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 28, 2021. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,543.32 delivery order contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a 120 ml medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,016.24 firm fixed price delivery order is from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the drug Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The award falls under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,409.08 firm fixed-price delivery order is for the drug Quillivant XR 25 mg/5 ml suspension, with a completion date of September 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,364.54 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a firm fixed-price delivery order with an ultimate completion date of August 31, 2023. This award is not associated with a set-aside program, indicating open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,267.36 firm fixed price delivery order is for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, with an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC...